GlassScriptPhysician profile
Kenneth Ray Johnson
NPI 1962784785
$1,616.62
in general payments reported to CMS, 2019-2025
17 companies · $498 in 2025
The $498 reported for 2025 was more than what 80% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.33 · 2022: $170 · 2023: $416 · 2024: $443 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.60 |
| Education | $168.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $380.16 | 2021-2025 | Otezla, Otezla |
| Genzyme Corporation | $183.91 | 2022-2025 | |
| Janssen Biotech, INC. | $183.63 | 2023-2024 | Tremfya |
| Dermavant Sciences, INC. | $142.27 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $120.37 | 2023-2025 | |
| Pfizer INC. | $104.18 | 2021-2025 | |
| Abbvie INC. | $100.59 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $72.15 | 2022 | |
| Lilly USA, LLC | $71.56 | 2023-2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $49.82 | 2024-2025 | Anzupgo, Adbry |
| Ucb, INC. | $47.71 | 2025 | Bimzelx |
| Incyte Corporation | $40.01 | 2023-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.46 | 2021-2024 | Arazlo, Cabtreo, Jublia |
| Galderma Laboratories, L.P. | $24.08 | 2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $22.76 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20.50 | 2025 | |
| Verrica Pharmaceuticals INC. | $17.46 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.